TGR BioSciences, a leading global provider of advanced cell based assay technologies in the fields of cancer, kinase and GPCR research, is extremely pleased to announce a distribution partnership with Axxora.com of San Diego, CA, US, a leading online global market place resource for innovative and high quality Life Science research reagents.
“We pride ourselves on offering uniquely innovative and high performing reagents from some of the World's best specialist manufacturers”
Axxora.com will become a distributor of TGR's new ELISAONE™ technology assay reagents in the US and South America. ELISAONE™ immunoassay kits for cellular phosphoprotein detection are immediately available to purchase online from Axxora.com, with further additions to the portfolio coming soon.
"We're thrilled to be expanding our distribution capabilities of ELISAONE™ through such a trusted and innovative resource as Axxora.com", says Leanna Read, CEO and Managing Director of TGR BioSciences. "Axxora.com will provide an easy and efficient means for our clients to access our phosphoprotein portfolio content, and will help us grow our presence and revenues throughout the Americas. We feel our ELISAONE™ platform has several distinct practical advantages over current ELISAs, and will bring significant savings in assay time and expenditure for clients, while often yielding improved sensitivity".
"We pride ourselves on offering uniquely innovative and high performing reagents from some of the World's best specialist manufacturers", says Brian Conkle, President at Axxora. "The ELISAONE™ phosphoprotein assays from TGR offer a unique combination of speed, sensitivity and flexibility for customers, and we expect these to be highly competitive with the more laborious ELISA market choices currently available".
Generative AI falls short in accurately identifying global health policies